Skip to content

Clinical trials

Observational Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Phase: Observational Country / region: United States Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20071
20082
20092
20102
20221
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting5
Terminated2
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UNC Lineberger Comprehensive Cancer Center2
Allotera Therapeutics1
Case Comprehensive Cancer Center1
City of Hope Medical Center1
Columbia University1
Eastern Cooperative Oncology Group1
Mayo Clinic1
Memorial Sloan Kettering Cancer Center1
National Cancer Institute (NCI)1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma14
Leukemia, Lymphocytic, Chronic, B-Cell11
Lymphoma, T-Cell, Cutaneous11
Precursor Cell Lymphoblastic Leukemia-Lymphoma11
Immunoblastic Lymphadenopathy10
Lymphoma, Large-Cell, Anaplastic10
Lymphoma, Non-Hodgkin10
Mycosis Fungoides10
Sezary Syndrome10
Burkitt Lymphoma9

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.